ABEONA THERAPEUTICS INC. Convertible Debt, Current
ABEONA THERAPEUTICS INC. (ABEO) had Convertible Debt, Current of $2.75 million as of 2012-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2012-05-15
- 2012-03-31: Convertible Debt, Current $2.75M.
- 2011-12-31: Convertible Debt, Current $2.75M.
- 2011-09-30: Convertible Debt, Current $5.50M.
- 2011-06-30: Convertible Debt, Current $2.75M.
| Period end | Convertible Debt, Current |
|---|---|
| 2012-03-31 | $2.75M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $2.75M 10-Q · filed 2012-05-15 |
| 2011-09-30 | $5.50M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.75M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $5.50M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |